US 11,952,385 B1
12-bromo-2,16-dioxa-9,9,18,18-tetramethylpentacyclo[7.7.5.0 1, 21.0 3,8.0 10,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound
Hany Mohamed Abd El-Lateef Ahmed, Al-Ahsa (SA); Mai Mostafa Khalaf Ali, Al-Ahsa (SA); and Antar Ahmed Abdelhamid Ahmed, Sohag (EG)
Assigned to KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed by KING FAISAL UNIVERSITY, Al-Ahsa (SA)
Filed on Oct. 31, 2023, as Appl. No. 18/385,861.
Int. Cl. C07D 493/08 (2006.01); A61P 31/04 (2006.01); A61P 31/10 (2006.01)
CPC C07D 493/08 (2013.01) [A61P 31/04 (2018.01); A61P 31/10 (2018.01)] 6 Claims
 
1. A method of treating a microbial infection in a patient comprising administering to a patient in need thereof a therapeutically effective amount of a 12-bromo-2,16-dioxa-9,9,18,18-tetramethylpentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione compound having the formula I:

OG Complex Work Unit Chemistry